MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-11-22: Reporting owner ROLIH SUSAN; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-11-11: Reporting owner KRAEUTLER JOHN A; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-07-26: Reporting owner BALDINI LAWRENCE; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-07-26: Reporting owner BALDINI LAWRENCE; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-11-22 | ROLIH SUSAN Officer (EVP, Reg & Quality Systems) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $4.53 exercise price | 2013-11-26 | |
| 2013-11-11 | KRAEUTLER JOHN A Director, Officer (Chief Executive Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,250 0 owned after | $4.53 exercise price | 2013-11-13 | |
| 2013-07-26 | BALDINI LAWRENCE Officer (Exec VP, Operations & IS) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,250 0 owned after | $7.28 exercise price | 2013-07-30 | |
| 2013-07-26 | BALDINI LAWRENCE Officer (Exec VP, Operations & IS) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,500 0 owned after | $14.01 exercise price | 2013-07-30 | |
| 2013-07-26 | BALDINI LAWRENCE Officer (Exec VP, Operations & IS) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $16.55 exercise price | 2013-07-30 | |
| 2013-07-26 | BALDINI LAWRENCE Officer (Exec VP, Operations & IS) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 500 owned after | $19.71 exercise price | 2013-07-30 | |
| 2013-07-01 | ROLIH SUSAN Officer (EVP, Reg & Quality Systems) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $21.75 exercise price | 2013-07-03 | |
| 2013-01-23 | READY ROBERT J Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $20.38 exercise price | 2013-01-24 | |
| 2013-01-23 | PHILLIPS DAVID Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $20.38 exercise price | 2013-01-24 | |
| 2013-01-23 | Anderson James M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $20.38 exercise price | 2013-01-24 |